Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Raffa

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Journal of Pain Research|January 31, 2020
Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic PainJoseph V Pergolizzi, Robert B Raffa
Cureus|May 6, 2024
Bracketing Estimation of Intentional Polysubstance Use in the United StatesRobert B Raffa, Joseph V Pergolizzi
Advances in Experimental Medicine and Biology|August 27, 2010
Future directionsRobert B Raffa, Ronald J Tallarida
Obesity (Silver Spring, Md.)|April 9, 2011
Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapiesSara Jane Ward, Robert B Raffa
British Journal of Clinical Pharmacology|February 3, 2012
Intracerebroventricular opioids for intractable painRobert B Raffa, Joseph V Pergolizzi
Cureus|June 7, 2024
Bispecific Sigma1R-Antagonist/MOR-Agonist Compounds for PainRobert B Raffa, Joseph V Pergolizzi
European Journal of Pharmacology|March 21, 2007
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonistsRobert B Raffa, Federica Cavallo, Anna Capasso
Journal of Pain Research|June 3, 2021
Benefit-Risk Analysis of Buprenorphine for Pain ManagementMartin Hale, Mark Garofoli, Robert B Raffa
Substance Abuse and Rehabilitation|January 30, 2014
Naltrexone extended-release injection: an option for the management of opioid abuseRobert Taylor, Robert B Raffa, Joseph V Pergolizzi
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in miceRonald J Tallarida, Alan Cowan, Robert B Raffa
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Journal of Pain Research|January 31, 2020
Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic PainJoseph V Pergolizzi, Robert B Raffa
Cureus|May 6, 2024
Bracketing Estimation of Intentional Polysubstance Use in the United StatesRobert B Raffa, Joseph V Pergolizzi
Advances in Experimental Medicine and Biology|August 27, 2010
Future directionsRobert B Raffa, Ronald J Tallarida
Obesity (Silver Spring, Md.)|April 9, 2011
Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapiesSara Jane Ward, Robert B Raffa
British Journal of Clinical Pharmacology|February 3, 2012
Intracerebroventricular opioids for intractable painRobert B Raffa, Joseph V Pergolizzi
Cureus|June 7, 2024
Bispecific Sigma1R-Antagonist/MOR-Agonist Compounds for PainRobert B Raffa, Joseph V Pergolizzi
European Journal of Pharmacology|March 21, 2007
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonistsRobert B Raffa, Federica Cavallo, Anna Capasso
Journal of Pain Research|June 3, 2021
Benefit-Risk Analysis of Buprenorphine for Pain ManagementMartin Hale, Mark Garofoli, Robert B Raffa
Substance Abuse and Rehabilitation|January 30, 2014
Naltrexone extended-release injection: an option for the management of opioid abuseRobert Taylor, Robert B Raffa, Joseph V Pergolizzi
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in miceRonald J Tallarida, Alan Cowan, Robert B Raffa
Pageof 20